drugset / Trial / NCT00515684
Corneal Thinning During Topical Bevacizumab Therapy
Withdrawn
Yonsei University
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.
Timeline
- Start
- 2007-05
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | — | Topical |